The 2025 Impact Factor Of Cell Genomics: 5 Shocking Metrics That Define Its Elite Status

The latest data confirms that *Cell Genomics* has rapidly ascended to become one of the most prestigious and influential journals in the world of life sciences, specifically within the burgeoning field of single-cell analysis. As of the most recent reporting periods, the journal's key metrics, including its Impact Factor, place it firmly in the elite Q1 quartile, reflecting the high quality and significant citation rate of the cutting-edge research it publishes. The journal is a critical publication for anyone tracking advancements in genetics, molecular biology, and the revolutionary technologies that allow scientists to study biological processes at the highest resolution. The journal’s performance in the latest citation reports underscores its role as a primary venue for breakthrough studies, particularly those involving spatial transcriptomics and multi-omic discovery. Published by Cell Press/Elsevier, *Cell Genomics* has quickly established a reputation for fast-tracking papers that move the needle in understanding cellular heterogeneity, disease mechanisms, and the development of comprehensive cell atlases. This article breaks down the most current and projected metrics, revealing why this publication is essential reading for researchers and investors alike in December 2025.

Cell Genomics: The Definitive Metrics Profile (2024-2025)

To fully appreciate the influence of *Cell Genomics*, it is crucial to look beyond a single number. The journal's profile is defined by a collection of inter-related metrics from the world's leading citation authorities, including Clarivate's Journal Citation Reports (JCR) and Scopus.

• Journal Title: *Cell Genomics*
• Publisher: Cell Press (Elsevier)
• ISSN: 2666-979X
• Discipline Categories: Biochemistry, Genetics & Molecular Biology (Miscellaneous), Genetics
• Latest JCR Impact Factor (IF): 9.0 (Projected/Reported for 2025 release)
• Current Impact Factor (IF) Variation: 7.85 (Reported in 2024)
• Latest Scopus Impact Score (IS): 5.83 (Computed in 2023, referred to as 2024 data)
• SCImago Journal Rank (SJR): 6.238
• H-index: 31
• Quartile Ranking (Q-Rank): Q1 (Top Quartile in all relevant categories)
• Percentage Rank (Genetics & Heredity): 95.3%

The key takeaway from this profile is the consistent presence in the Q1 quartile across multiple ranking systems. This status confirms that *Cell Genomics* is among the top 25% of all journals in its respective fields, a significant achievement for a relatively new publication.

5 Shocking Metrics That Define Cell Genomics' Elite Status

The true value of a journal's Impact Factor is in what it reveals about the quality and influence of the research it disseminates. The following five metrics solidify *Cell Genomics*'s position as a powerhouse in the genomics landscape.

1. The Projected JCR Impact Factor of 9.0

The most anticipated metric, the Journal Impact Factor (JIF) released by Clarivate, is reported to be as high as 9.0 in the latest projections and data releases. This number represents the average number of citations received per article published in the journal during the preceding two years. A value of 9.0 is exceptionally high for any scientific journal, particularly one focused on a niche as specialized as single-cell genomics. It demonstrates an extraordinary frequency of citation, meaning that the papers published here are immediately and widely referenced by the global scientific community. This high IF is a direct indicator of the journal's immediate and profound influence on the direction of modern biological research.

2. Consistent Q1 Quartile Ranking

A journal's Quartile Ranking (Q-Rank) is often a more stable and reliable indicator of quality than the IF alone. *Cell Genomics* is consistently ranked in the Q1 quartile in all its primary subject categories, including Genetics and Biochemistry, Genetics and Molecular Biology (miscellaneous). This Q1 status is a benchmark for excellence, signifying that the journal is among the top 25% of all peer-reviewed journals in its field. For researchers, publishing in a Q1 journal is a career-defining achievement, and for institutions, it is a marker of high-impact research output. The journal's percentage rank of 95.3% in the GENETICS & HEREDITY category further emphasizes its standing at the very top of the field.

3. The SCImago Journal Rank (SJR) of 6.238

The SCImago Journal Rank (SJR) is a metric that factors in the prestige of the journals that cite the articles, not just the raw number of citations. An SJR of 6.238 is a powerful statement. This metric operates on the principle that a citation from a high-prestige journal is worth more than a citation from a low-prestige one. The high SJR for *Cell Genomics* indicates that its research is not only cited frequently but is being heavily cited by other top-tier, high-impact publications, confirming its central role in the scientific discourse.

4. The H-index of 31

The journal’s H-index stands at 31. The H-index is a measure of both the productivity and the citation impact of a journal's publications. An H-index of 31 means that *Cell Genomics* has published 31 papers that have each been cited at least 31 times. This metric is less susceptible to short-term fluctuations than the Impact Factor and provides a long-term view of the journal’s sustained influence. It is a testament to the enduring quality and relevance of the single-cell sequencing and spatial biology research it champions.

5. Rapid Adoption of Multi-Omic and Spatial Technologies

The high citation metrics are not accidental; they are driven by the journal's focus on the most transformative technologies in modern biology. *Cell Genomics* has positioned itself as the leading venue for papers on single-cell RNA sequencing (scRNA-Seq), Single-Cell DNA Sequencing, and the emerging field of Spatial Transcriptomics. The research published often introduces novel computational frameworks, such as NovoSpaRc for *de novo* spatial reconstruction, or new tools like CellWalker2 for multi-omic discovery. By prioritizing these cutting-edge methodologies, the journal ensures its content is at the forefront of scientific progress, leading to higher citation rates. For instance, studies on the Global Biobank Meta-analysis Initiative and systematic single-variant and gene-based association testing are prime examples of the high-impact genetic discovery being published.

The Future of Single-Cell Research and Cell Genomics

The field of cellular genomics is experiencing a revolutionary phase, moving from bulk analysis to high-resolution, cell-by-cell investigation. *Cell Genomics* is perfectly positioned to capture this momentum. The journal is a key player in the global effort to create comprehensive cell atlases, which map every cell type in the human body and other organisms. The articles published frequently delve into complex topics like cellular metabolism, genome integrity, and the mechanisms of cell cycle progression at the single-cell level. As technologies continue to advance, allowing for deeper integration of single-cell epigenome sequencing and other multi-modal data, the journal's role as a central hub for these discoveries will only grow. Its robust Impact Factor and Q1 ranking are not just historical metrics; they are indicators of its future as the premier destination for high-impact research in the era of precision medicine and spatial biology. Researchers aiming for the top of the Genetics & Heredity category will continue to target *Cell Genomics* as the gold standard for publishing their most significant findings.

Detail Author:

• Name : Dr. Lexie Willms V
• Username : kyra25
• Email : jacobs.ayana@hotmail.com
• Birthdate : 2005-12-23
• Address : 85633 Braun Extensions South Karli, MI 29143-4173
• Phone : 385.234.8875
• Company : Casper Inc
• Job : Fish Hatchery Manager
• Bio : Est et excepturi similique aut. At vel veritatis provident nisi. Ullam eius eum consequatur quas suscipit.

Socials

tiktok:

• url : https://tiktok.com/@thielm
• username : thielm
• bio : Quae aspernatur sed nostrum sed.
• followers : 4280
• following : 2025

twitter:

• url : https://twitter.com/maida_thiel
• username : maida_thiel
• bio : Ipsa expedita sint porro aspernatur molestias quisquam. Officiis maxime qui velit dolores doloremque illo asperiores. Quibusdam recusandae natus illo mollitia.
• followers : 3752
• following : 1929

linkedin:

• url : https://linkedin.com/in/maidathiel
• username : maidathiel
• bio : Nobis vel hic et minus in.
• followers : 4684
• following : 2595

instagram:

• url : https://instagram.com/maida.thiel
• username : maida.thiel
• bio : Dolorum sapiente eos earum laboriosam ducimus. Vitae id voluptas omnis sint deserunt itaque.
• followers : 5506
• following : 1457